RORA and colorectal carcinoma: In addition, the combination of RORα/γ agonists and atorvastatin synergistically killed CRC cells and inhibited CRC metastasis, suggesting that targeting the cholesterol-RORα/γ axis is a new therapeutic approach for CRC.